Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

Blocking certain immune signals can reduce skin damage from radiation therapy.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

Janus kinase inhibitors may help treat lichen planopilaris.

JAK inhibitors may help treat alopecia areata in children, but their safety needs careful evaluation.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Certain compounds from Kushtakudori ennai may help treat hair loss.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Ajuga reptans L. extracts have strong antioxidant, anti-inflammatory, liver-protective, antimicrobial, and wound-healing properties.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Jumonji genes are important for development and their mutations can cause abnormalities, especially in the heart and brain.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

Diazoxide, minoxidil sulphate, and cromakalim relax rat blood vessels by opening K+ channels, with some differences in their actions.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Combining these plant extracts kills mosquito larvae effectively.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Certain drugs can block changes in brain receptors caused by alcohol withdrawal.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.